Showing results (861-870 of 2,037) with videos related to
Sort By:
Pageof 204
Nuklearmedizin. Nuclear Medicine|December 1, 1979
Technical parameters of in vivo red blood cell labeling with Technetium-99mA M Zimmer, D G Pavel, S M KareshNuklearmedizin. Nuclear Medicine|February 1, 1979
A method for subtraction of the extrarenal "background" in dynamic 131I-hippurate renoscintigraphyE Mlodkowska, J Liniecki, M SurmaNuklearmedizin. Nuclear Medicine|September 26, 2025
Diagnostic Performance of 99 mTc-Sestamibi SPECT/CT and 18F-Choline PET/CT in Locating Hyperfunctioning Parathyroid Glands in Patients with Primary HyperparathyroidismAnte Mandic, Ivana Kraljevic, Tanja Skoric Polovina, et al.Nuklearmedizin. Nuclear Medicine|September 19, 2013
Catecholamines influence myocardial 123I MIBG uptake in neuroblastoma patientsR L F van der Palen, B F Bulten, A M C Mavinkurve-Groothuis, et al.Nuklearmedizin. Nuclear Medicine|August 8, 2014
CA 15.3 measurements for separating FDG PET/CT positive from negative findings in breast carcinoma recurrence. Factors influencing the area under the ROC curveV Kruse, C Van de Wiele, M Borms, et al.Nuklearmedizin. Nuclear Medicine|December 6, 2013
Splenic FDG uptake predicts poor prognosis in patients with unresectable cholangiocarcinomaK Pak, S-J Kim, I J Kim, et al.Nuklearmedizin. Nuclear Medicine|May 18, 2013
18F-FDG PET/CT findings in patients with Kikuchi diseaseE Kong, K Chun, Y Hong, et al.Nuklearmedizin. Nuclear Medicine|February 14, 2013
Improved follow-up of patients with differentiated thyroid carcinoma. The quantitative detection limit of 131I uptake in diagnostic scansS Dießl, F Verburg, J Biko, et al.Nuklearmedizin. Nuclear Medicine|February 8, 2013
[Metastases in patients with breast cancer despite of negative sentinel lymph node. Has the concept to be changed?]M Weiss, M Meyer, S Siegert, et al.Nuklearmedizin. Nuclear Medicine|March 1, 1990
Cholescintigraphy versus infusion cholecystography in acute cholecystitisG Edlund, V KempiPageof 204